The ISSCR led a group of scientists to Washington, DC, U.S. to garner support for policies important to stem cell research and the broader biomedical research community. The scientists met with representatives from 17 Congressional Offices to discuss the protection of fetal tissue research, the need for additional enforcement to curb the marketing and use of unproven products, and the importance of NIH funding for biomedical research.

The ISSCR is pleased to announce the recipients of the inaugural Lawrence Goldstein Policy Fellowship, Mohamed Abou El-Enein, PhD (Charité Universitätsmedizin, Berlin, Germany) and Zubin Master, PhD (Mayo Clinic, Rochester, MN, U.S.).

Polices created by legislators and regulators can have a profound impact on stem cell and biomedical research and the development of new treatments. The ISSCR has been working on several fronts to advocate for responsible stem cell research and its application. Read more about the recent ISSCR-led fly in to Washington D.C. for discussions with government officials and our consultations with Google to prevent the marketing of unproven stem cell therapies.

The ISSCR Education Committee is compiling educational resources on stem cell science and its applications to support the teaching needs of our constituents. To help the Education Committee create the course syllabus, we are asking you for examples of your syllabi on courses related to stem cell biology, translational medicine, and clinical applications.

The International Society for Stem Cell Research (ISSCR) today released the following statement regarding Google’s new policy that bans advertisements from unproven stem cell clinics and other speculative medical interventions.

The ISSCR is soliciting nominations to honor exceptional and innovative research and support for young scientists and the future of the field, through its extensive awards program. It also invites members to nominate candidates to serve on the ISSCR board of directors.

The International Society for Stem Cell Research (ISSCR) today released a professional standard of informed consent for stem cell-based interventions performed outside of formal clinical trials, such as the unapproved and unproven “treatments” offered by clinicians at direct-to-consumer clinics. The standard is meant to help ensure that patients are informed about the potential benefits and risks of stem cell-based medical interventions, and was developed with input from clinicians, ethicists, researchers, and regulators from around the world.

As stem cell researchers, we are in a unique position to make real and meaningful impacts in the world. During my time as ISSCR President my goal, beyond serving ISSCR’s role as the main convener of stem cell science, is to strengthen the society’s voice and influence by expanding on our global policy initiatives and helping foster industry-academic partnerships to accelerate the safe and effective clinical translation of stem cell research.

Nearly 4,000 scientists, physicians, and stem cell professionals from across the globe gathered at the ISSCR 2019 Annual Meeting in Los Angeles, CA, a vibrant city with world-class stem cell research, to share their discoveries, enhance their careers, and inspire their science.

We asked Naomi Koh Belic, a PhD candidate from the University of Technology Sydney, for her perspective as a trainee attending the ISSCR Annual Meeting for the third year. Naomi shares some highlights and tips from ISSCR2019 in Los Angeles.

The ISSCR is pleased to announce Deepak Srivastava, MD, Gladstone Institutes, as the incoming president of the ISSCR and its board of directors. Srivastava assumed the post immediately following the 17th ISSCR Annual Meeting in Los Angeles, 26-29 June, 2019.

The ISSCR honored longtime member Lawrence Goldstein for his years of science policy advocacy, and announced a new program in his name that will train ISSCR members to become stem cell policy advocates. The tribute and introduction of the Lawrence Goldstein Science Policy Fellowship program was part of the opening plenary session of the ISSCR annual meeting, 26-29 in Los Angeles, Calif., U.S.

The International Society for Stem Cell Research annual meeting, 26-29 June at the Los Angeles Convention Center, will bring together more than 3,500 scientists, bioethicists, clinicians, industry professionals, and others from over 50 countries to share the latest developments in stem cell science and regenerative medicine.

The ISSCR and other medical, scientific, educational, and healthcare groups sent a letter to members of the U.S. Congress supporting an amendment that would prevent the implementation of a new policy to restrict and delay federal funding for fetal tissue research.

The ISSCR commends the U.S. District Court ruling that confirms the FDA’s authority to regulate clinics marketing and selling unproven therapies as stem cell products. The clinic, U.S. Stem Cell, has injected cells derived from fat into the eyes of several patients, resulting in at least three being blinded.